CARsgen Therapeutics Holdings Ltd. (HK:2171) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CARsgen Therapeutics Holdings Ltd. has granted 2,667,000 share options to 31 individuals under its Post-IPO Share Option Scheme, with an exercise price of HK$7.26 per share. These options, which are set to vest over a four-year period, aim to incentivize employees without performance targets attached. The company has clarified that no financial assistance has been provided to the grantees for purchasing shares.
For further insights into HK:2171 stock, check out TipRanks’ Stock Analysis page.